Expression, purification, crystallization and X-ray analysis of 3-quinuclidinone reductase fromAgrobacterium tumefaciens
Open Access
- 29 September 2012
- journal article
- crystallization communications
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology and Crystallization Communications
- Vol. 68 (10) , 1237-1239
Abstract
(R)-3-Quinuclidinol is a useful chiral building block for the synthesis of various pharmaceuticals and can be produced from 3-quinuclidinone by asymmetric reduction. A novel 3-quinuclidinone reductase from Agrobacterium tumefaciens (AtQR) catalyzes the stereospecific reduction of 3-quinuclidinone to (R)-3-quinuclidinol with NADH as a cofactor. Recombinant AtQR was overexpressed in Escherichia coli, purified and crystallized with NADH using the sitting-drop vapour-diffusion method at 293 K. Crystals were obtained using a reservoir solution containing PEG 3350 as a precipitant. X-ray diffraction data were collected to 1.72 Å resolution on beamline BL-5A at the Photon Factory. The crystal belonged to space group P21, with unit-cell parameters a = 62.0, b = 126.4, c = 62.0 Å, = 110.5°, and was suggested to contain four molecules in the asymmetric unit (V M = 2.08 Å3 Da-1).Keywords
This publication has 14 references indexed in Scilit:
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Enzymatische Technologien zur Synthese chiraler Alkohol‐DerivateChemie Ingenieur Technik, 2006
- Synthesis and Biological Evaluation of Quinuclidine Derivatives Incorporating Phenothiazine Moieties as Squalene Synthase InhibitorsChemical and Pharmaceutical Bulletin, 2004
- Crystal Structure of meso-2,3-Butanediol Dehydrogenase in a Complex with NAD+ and Inhibitor Mercaptoethanol at 1.7 A Resolution for Understanding of Chiral Substrate Recognition MechanismsThe Journal of Biochemistry, 2001
- Pharmacokinetics of the M1-agonist talsaclidine in mouse, rat, rabbit and monkey, and extrapolation to manXenobiotica, 2000
- Discovery & development of selective M3 antagonists for clinical useLife Sciences, 1997
- How to measure and predict the molar absorption coefficient of a proteinProtein Science, 1995
- Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constantsJournal of Applied Crystallography, 1993
- Affinity and selectivity of the optical isomers of 3-quinuclidinyl benzilate and related muscarinic antagonistsJournal of Medicinal Chemistry, 1988
- Solvent content of protein crystalsJournal of Molecular Biology, 1968